Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressin
- 31 January 1984
- journal article
- Published by Elsevier in Trends in Neurosciences
- Vol. 7 (1) , 6-9
- https://doi.org/10.1016/s0166-2236(84)80179-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neuropeptides — what next?Trends in Neurosciences, 1983
- A Major Metabolite of Arginine Vasopressin in the Brain Is a Highly Potent NeuropeptideScience, 1983
- Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressinNature, 1983
- In vitro CRF activity of vasopressin analogs is not related to pressor activityEuropean Journal of Pharmacology, 1983
- Characterization of 3H-AVP binding sites in particulate preparations of rat brainPeptides, 1983
- Design of Potent and Selective In Vivo Antagonists of the Neurohypophysial PeptidesPublished by Elsevier ,1983
- Hormonally Active Arginine-Vasopressin Suppresses Endotoxin-Induced Fever in Rats: Lack of Effect of Oxytocin and a Behaviorally Active Vasopressin FragmentNeuroendocrinology, 1983
- In Vivo Adrenocorticotropin-Releasing Activity of Neurohypophyseal Hormones and Their Analogs*Endocrinology, 1982
- Arginine vasopressin and a vasopressin antagonist peptide: Opposite effects on extinction of active avoidance in ratsRegulatory Peptides, 1981
- The nature of the hepatic receptors involved in vasopressin-induced glycogenolysisBiochimica et Biophysica Acta (BBA) - General Subjects, 1979